DNLI - Denali Therapeutics Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - DNLI (1714899)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
33 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-06-10
DNLISchuth Alexander O.COO, SecretaryS - Sale$18.77-7,500648,327-1%-$140,775
D
2019-06-10
DNLIHo CaroleChief Medical OfficerS - Sale+OE$18.78-17,500162,798-10%-$328,653
2019-06-03
DNLIWatts Ryan J.Pres, CEOS - Sale$19.07-18,3332,573,476-1%-$349,610
M
2019-05-09
DNLISchuth Alexander O.COO, SecretaryS - Sale$22.05-7,500655,827-1%-$165,350
DM
2019-05-08
DNLIHo CaroleChief Medical OfficerS - Sale+OE$22.85-17,500175,681-9%-$399,901
ADM
2019-04-01
DNLIHo CaroleChief Medical OfficerS - Sale+OE$25.44-36,912194,957-16%-$938,976
M
2019-05-01
DNLIWatts Ryan J.Pres, CEOS - Sale$24.20-18,3342,591,809-1%-$443,744
M
2019-04-09
DNLISchuth Alexander O.COO, SecretaryS - Sale$28.05-7,500663,327-1%-$210,396
2019-04-04
DNLIHo CaroleChief Medical OfficerS - Sale$26.35-9,588185,369-5%-$252,678
DM
2019-04-01
DNLIHo CaroleChief Medical OfficerS - Sale+OE$25.44-36,805194,957-16%-$936,285
M
2019-04-01
DNLIWatts Ryan J.Pres, CEOS - Sale$25.03-18,3332,597,638-1%-$458,800
D
2019-03-14
DNLIHo CaroleChief Medical OfficerS - Sale+OE$25.01-1,000213,9900%-$25,010
M
2019-03-11
DNLISchuth Alexander O.COO, SecretaryS - Sale$22.58-7,500670,827-1%-$169,313
DM
2019-03-01
DNLIHo CaroleChief Medical OfficerS - Sale+OE$22.17-17,500214,490-8%-$388,000
M
2019-03-01
DNLIWatts Ryan J.Pres, CEOS - Sale$22.18-18,3332,628,476-1%-$406,601
M
2019-02-08
DNLISchuth Alexander O.COO, SecretaryS - Sale$19.08-7,500678,327-1%-$143,089
DM
2019-02-01
DNLIHo CaroleChief Medical OfficerS - Sale+OE$18.72-17,500214,490-8%-$327,589
M
2019-02-01
DNLIWatts Ryan J.Pres, CEOS - Sale$18.72-18,3342,646,809-1%-$343,300
M
2019-01-09
DNLISchuth Alexander O.COO, SecretaryS - Sale$20.37-7,500685,827-1%-$152,750
DM
2019-01-02
DNLIHo CaroleChief Medical OfficerS - Sale+OE$19.55-14,502217,267-6%-$283,506
M
2019-01-02
DNLIWatts Ryan J.Pres, CEOS - Sale$19.43-18,3332,665,143-1%-$356,288
M
2018-12-10
DNLISchuth Alexander O.COO, SecretaryS - Sale$20.40-7,500693,327-1%-$153,000
2018-12-03
DNLIHo CaroleChief Medical OfficerS - Sale$18.45-17,500220,265-7%-$322,834
2018-12-03
DNLIWatts Ryan J.Pres, CEOS - Sale$18.43-18,3332,683,476-1%-$337,938
2018-11-15
DNLIHo CaroleChief Medical OfficerS - Sale$18.07-17,500237,765-7%-$316,157
M
2018-11-13
DNLIWatts Ryan J.Pres, CEOS - Sale$18.09-18,3342,741,809-1%-$331,664
2018-10-01
DNLIWatts Ryan J.Pres, CEOS - Sale$21.72-18,3332,760,143-1%-$398,193
2018-10-01
DNLIHo CaroleChief Medical OfficerS - Sale$21.72-17,500255,265-6%-$380,100
2018-09-04
DNLIHo CaroleChief Medical OfficerS - Sale$19.05-17,500272,765-6%-$333,375
2018-09-04
DNLIWatts Ryan J.Pres, CEOS - Sale$19.06-18,3332,778,476-1%-$349,427
2018-08-29
DNLIHo CaroleChief Medical OfficerS - Sale$18.04-17,500290,265-6%-$315,700
2018-08-29
DNLIWatts Ryan J.Pres, CEOS - Sale$18.05-18,3342,796,809-1%-$330,929
D
2017-12-12
DNLIBratton Douglas K10%P - Purchase$18.00+275,00020,574,298+1%+$4,950,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top